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Introduction
The general role of the erythrocyte membrane skeleton
is well known. It maintains the shape and the membrane
mechanical properties of this cell. In other tissues, mem-
brane-associated cytoskeletal proteins are also involved
in the control of cell-cell and cell-matrix attachments.
They also have roles to play in the organization of spe-
cialized membrane domains. The main component of
the red blood cell membrane skeleton is spectrin. This
fibrous polypeptide acts as a scaffold in the membrane
skeleton meshwork. The spectrin tetramers are attached
to the membrane by the protein ankyrin, which is linked
through its ank-repeat region to band 3 dimers and pro-
tein 4.1, which forms a ternary complex with gly-
cophorin C and the membrane-associated guanylate
kinase p55 [for review see 12]. Other proteins of the
membrane skeleton, such as actin, tropomyosin, tropo-
modulin and dematin form the junction with spectrin at
its nodes. 
This review is devoted to protein 4.1, a multifunc-
tional membrane protein which stabilizes the spectrin-
actin association. This 80-kDa protein, which is essen-
tial for normal cell shape and integrity, provides con-
nections between the skeleton and the plasma mem-
brane in erythrocytes, but also plays an important role in
several cell functions in many other tissues/organs,
including the bone marrow, cerebellum, lungs, testes
and thymus [130]. Protein 4.1 is also a prototype of a
large superfamily of proteins, the members of which
share a common more or less homologous domain
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Abstract: The review is focused on the domain structure and function of protein 4.1, one of the proteins belonging to the mem-
brane skeleton. The protein 4.1 of the red blood cells (4.1R) is a multifunctional protein that localizes to the membrane skele-
ton and stabilizes erythrocyte shape and membrane mechanical properties, such as deformability and stability, via lateral inter-
actions with spectrin, actin, glycophorin C and protein p55. Protein 4.1 binding is modulated through the action of kinases
and/or calmodulin-Ca2+. Non-erythroid cells express the 4.1R homologues: 4.1G (general type), 4.1B (brain type), and 4.1N
(neuron type), and the whole group belongs to the protein 4.1 superfamily, which is characterized by the presence of a highly
conserved FERM domain at the N-terminus of the molecule. Proteins 4.1R, 4.1 G, 4.1 N and 4.1 B are encoded by different
genes. Most of the 4.1 superfamily proteins also contain an actin-binding domain. To date, more than 40 members have been
identified. They can be divided into five groups: protein 4.1 molecules, ERM proteins, talin-related molecules, protein tyrosine
phosphatase (PTPH) proteins and NBL4 proteins. We have focused our attention on the main, well known representatives of
4.1 superfamily and tried to choose the proteins which are close to 4.1R or which have distinct functions. 4.1 family proteins
are not just linkers between the plasma membrane and membrane skeleton; they also play an important role in various process-
es. Some, such as focal adhesion kinase (FAK), non-receptor tyrosine kinase that localizes to focal adhesions in adherent cells,
play the role in cell adhesion. The other members control or take part in tumor suppression, regulation of cell cycle progres-
sion, inhibition of cell proliferation, downstream signaling of the glutamate receptors, and establishment of cell polarity; some
are also involved in cell proliferation, cell motility, and/or cell-to-cell communication. 
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Abbreviations: FERM - four.one protein, ezrin, radixin, moesin
(name of domain), NBL4 - novel band 4.1-like 4, NF2 - neurofi-
bromatosis type 2, PDZ - postsynaptic density-95/discs large/zona
occludens-1 domain, PIP2 - phosphatidylinositol 4,5-bisphos-
phate, PS - phosphatidylserine, PTPH - protein tyrosine phos-
phatase , PTPMEG - protein tyrosine phosphatase, megakaryocyte
named the FERM domain. It includes all homologues of
protein 4.1 and the ERM proteins - ezrin, radixin and
moesin. Talin and some types of protein tyrosine phos-
phatase, such as PRP-Meg and PTPH1, are also part of
this family [77]. The aim of this paper is to review recent
data on this large family of proteins, which play a role in
the structure and regulation of the membrane skeleton
and cytoskeleton, and are also involved in cell adhesion,
and in some cases in the regulation of the cell cycle. 
It should be noted that we have chosen to review
the proteins which are close to 4.1R or which have dis-
tinct functions, since to present the characteristics of
all members of the 4.1 superfamily in one review
would be a very difficult task, because in humans, for
instance, there are about 50 genes now known to
encode FERM domains (Table 1) which appear in
many proteins such as JAK kinases, unconventional
myosins and some GEFs among others. 
The structure of protein 4.1
Human protein 4.1 consists of 864 amino acid residues
(molecular weight: 97017 Da) and is a product of
human gene epb41 (http://www.expasy.org/uniprot/
(UniProtKB/Swiss-Prot: P11171). 
It should be noted that there are more residues in iso-
forms containing exons 17A and 17B and fewer in iso-
forms translated from ATG2 or ATG 3. Mentioning of all
these isoforms could complicate our review, so we have
decided to choose antitypical entries as examples of pre-
sented structures and proteins. Protein 4.1R consists of
four structural and functional domains (Fig. 1) [22].
The FERM domain
The very important N-terminal (30 kDa) domain, also
known as the FERM domain, is present in a wide range
of proteins called the ERM family (Fig. 2A) [20]. This
domain is encoded by exons 4 to 12 and is responsible
for the binding of protein 4.1R to other proteins such as
glycophorin C [37, 52], protein p55 [78, 79], and
calmodulin [93]. The analysis of the crystal structure of
the ERM domain led to the identification of 3 subdo-
mains, the N-, α- and C-lobes [49], called also A, B, and
C lobes, which form a clover leaf structure. Each lobe
contains a distinct region or regions that are responsible
for specific binding of different membrane proteins and
each of them represents a compactly folded structure.
The N-lobe contains the band 3 binding motif; the
sequence LEEDY encoded by exon 5 is the binding site
for the sequences IRRRY and LRRRY present in the
cytoplasmic domain of band 3 [65, 127]. This lobe has
a fold resembling ubiqiutin [31, 124]. The next lobe
(named the  α-lobe because it is formed by four  α-
helices) contains the glycophorin C-binding region and
resembles acyl-CoA binding proteins [31, 124]. The C-
lobe, containing the p55, CaM, PS and PIP2-binding
region, with two  β-sheets and an  α-helical end, has a
fold related to pleckstrin homology domain/phosphoty-
rosine-binding domain (PTB) [31, 124]. This binding
site is located in the region encoded by exon 10 and
associated with a positively charged, 39-amino acid
residue motif (D5 domain) within p55 [80, 94]. With all
these binding sites, the 30 kDa domain contributes to
the formation of the ternary complex of 4.1R, gly-
cophorin C and p55 [1, 80]. The C-lobe, C-terminal part
of FERM domain was also shown to interact with phos-
phatidylserine (PS) [2, 112] and calmodulin; the latter
requires the presence of Ca2+. The Ca2+-sensitive
calmodulin binding sites are situated between the α- and
C-lobes, and the Ca2+-insensitive between the C- and N-
lobes, in the regions encoded by exons 11 and 9, respec-
tively [49, 93]. The FERM domain is required during
erythropoiesis for the stable retention of glycophorin C
and p55 in the membrane [119]. 
The 16 kDa domain
The 16 kDa domain, which lacks any known binding
activities, separates the FERM domain and the next, 10
kDa domain. Its function is not yet clearly defined. It
was recorded that two serine residues, Ser312 and
Ser331, could be phosphorylated by protein kinase A
and protein kinase C. This means the16 kDa domain
possibly affects 4.1R interactions with band 3, gly-
cophorin C, spectrin and actin [59, 78]. 
The SABD domain
The 10 kDa domain, encoded by exons 13, 16 and 17,
binds spectrin, actin [23], U2AF35 and importin-α, a pro-
tein that is necessary for the nuclear import of protein
4.1R [38, 76]. This domain also contains residues such as
Ser467 and Tyr418, which can be phosphorylated by vari-
ous kinases [58, 78]. The primary structure of this
domain is highly conserved in many vertebrates, indicat-
ing conservation of its function [140], except for 4.1N
homologue of SAB domain, which is different and does
not bind spectrin and actin [40]. Also Drosophila 4.1
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Fig. 1. Schematic representation of the domain structure of protein
4.1R, on the basis of [4, 49, 126, 127]. Domains: CTD - carboxyl
terminal domain, FERM - 4.1-ezrin-radixin-moesin domain,
SABD -spectrin-actin-binding domain. Receptors: BPA - band 3,
CaM - calmodulin, GPC - glycophorin C, p55 - protein p55, P -
phosphate group, PIP2 - phosphatidylinositol 4,5-bisphosphate, PS
- phosphatidylserine.
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Table 1. Human genes that are known to encode FERM domain IPR000299 located on Ensembl (http://www.ensembl.org/Homo_sapi-
ens/domainview?domainentry=IPR000299)
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Table 1. (cont.)
does not have this domain. The minimum consensus
sequence which is necessary for interactions with spec-
trin and actin (critical to the mechanical integrity of the
erythrocyte) is a 21-amino acid sequence consisting of
the residues Lys407-Glu427 [26]. This motif, which is
responsible for strong spectrin binding, is situated in the
middle of a 59-amino acid region and activates the spec-
trin-actin complex formation [27, 113], therefore playing
a crucial role in the mechanical stabilization of the mem-
brane [26]. 
The CTD domain
The C-terminal domain of protein 4.1 (CTD) is a 22/24
kDa domain, encoded by exons 18-21. The 2 kDa
molecular weight difference between protein 4.1Ra and
4.1Rb is a result of a conversion of asparagine Asn502 to
Asp502, which takes place during erythrocyte aging [61].
As a consequence, the mobility of 4.1R in SDS gel is
changed so that two isoforms can be distinguished. The
22/24 kDa domain is not stable and is rapidly processed
to a 15 kDa fragment by chymotrypsin [116]. This
smaller fragment is extremely stable, and is composed
of 5-6 β-sheets and an α helix preceding the C-terminal
helix. In nonerythroid cells, the 22/24 kDa domain is
known to interact with some proteins that form tight
junctions, such as occludin, zonula occludens-1 (ZO-1)
and zonula occludens-2 (ZO-2) [83]. Others suggest that
the erythroid C-terminal domain can bind the polypep-
tide eIF3-p44 subunit of the eukaryotic translation fac-
tor 3 (eIF3) complex [60]. Amino acid residues 525-622
of the C-terminus of protein 4.1R and a region (residues
54-321) of eIF3-p44 are essential for this interaction.
This association suggests a possible importance of pro-
tein 4.1 as a linker between the cytoskeleton network
and the translation apparatus [60].
The 4.1R-null mice have erythrocytes with abnor-
mal morphology, lowered membrane stability and
reduced expression of other skeletal proteins such as
spectrin and ankyrin. It suggests that loss of 4.1R com-
promises membrane skeleton assembly in erythroid
progenitors [119]. Thus, there are two separate func-
tions for 4.1R: mechanical stabilization of the mem-
brane and membrane protein targeting/retention.
The role of 4.1R in the organization 
of the membrane skeleton
The ability of 4.1R to bind various proteins is essential
for the organization of the red cell membrane skeleton.
The membrane skeleton network is created by numerous
horizontal interactions of the spectrin-actin network with
protein 4.1, adducin, tropomyosin, tropomodulin,
dematin and protein p55 [127]. Protein 4.1 is also neces-
sary for the vertical connections of the skeleton underly-
ing the red blood cell membrane with the protein pre-
ceptors present in the membrane, such as band 3 (in this
case, the linker is ankyrin) [81] or glycophorin C [77]
(Fig. 2A). All these interactions are essential in main-
taining the biconcave disc shape of the erythrocyte and
the mechanical properties of the membrane [86, 96]. The
affinity of 4.1 to the other membrane proteins can be reg-
ulated by calmodulin, which can bind to both Ca2+-
dependent and Ca2+-independent binding sites in protein
4.1 [93]. The interaction of a 10-kDa domain of protein
4.1 with the actin and spectrin β-subunit is very impor-
tant for the membrane stability of erythrocytes, and it
accelerates spectrin-actin interactions [96]. Interactions
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with both proteins can be modulated by various factors,
such as the binding of calmodulin-Ca2+ to protein 4.1R
[92, 129] or the phosphorylation of protein 4.1R [59,
103]. In the presence of Ca2+, calmodulin reduces the
affinity of protein 4.1R for the spectrin-actin complex
and decreases the membrane mechanical stability [92].
Similarly, the phosphorylation of protein 4.1 reduces its
ability to associate with spectrin by about 5-fold, and
may increase the relaxation of the skeleton and the flex-
ibility of the membrane structure [30]. Protein 4.1R can
be phosphorylated by a variety of kinases in vivo and in
vitro, including caseine kinase, tyrosine kinase, PKA and
PKC [59, 103]. It was shown that phosphorylation of
4.1R by protein kinase C decreases its ability to form a
ternary complex with spectrin and actin. Phosphoryla-
tion induces the dissociation of glycophorin C from the
membrane skeleton. Therefore the final effect of this
process is a marked decrease in the mechanical stability
of the erythrocyte membrane [78].
Protein 4.1 also interacts with glycophorin C and pro-
tein p55 [37, 80, 96]. These three protein interactions,
glycophorin C-protein 4.1, glycophorin C-p55 and p55-
protein 4.1, constitute the ternary complex in the ery-
throcyte membrane [1, 79]. The p55 and glycophorin C
binding sites were identified in the N-terminal 30-kDa
domain of protein 4.1R. They are encoded by exons 8
(responsible for 4.1R binding glycophorin C) and 10
(responsible for 4.1R binding p55) [94]. The binding of
protein 4.1 to p55 increases the affinity of the interaction
between p55 and glycophorin C, which implies a very
important role of protein 4.1R in the regulation of the
stability of the ternary protein complex (glycophorin C,
protein 4.1 and p55) involved in the "vertical" interac-
tions of the membrane skeleton with the membrane
bilayer [79, 94]. Protein 4.1 deficiency in the red blood
cell membrane causes a lack of glycophorin C and leads
to an elliptocytic erythrocyte morphology. Protein 4.1
seems to be required for the retention of normal amounts
of glycophorin C in the erythrocyte membrane [107].
In addition, protein 4.1 also binds to the cytoplasmic
domain of band 3 via its N-terminal 30-kDa domain
[19], and through this interaction, modulates band 3
binding to ankyrin, decreasing the affinity of band 3 for
ankyrin [3]. The association with calmodulin and Ca2+
reduces the binding affinity to band 3 [92]. These inter-
actions stabilize the mechanical resistance of the ery-
throcyte membrane [3]. Although most non-erythroid
cells lack band 3 and glycophorin C in their membranes,
they contain adhesion molecules, such as cadherins and
CD44, which could interact with protein 4.1 and its non-
erythroid analogues [95]. Protein 4.1 binds to the cyto-
plasmic domain of CD44 in a manner similar to binding
to band 3. Similarly, CD44-protein 4.1 interaction is also
decreased by Ca2+ and calmodulin [95]. CD44 was
found to associate with ankyrin [74]. Although protein
4.1 and ankyrin bind to distinctly different regions of the
cytoplasmic domain of CD44, the binding of protein 4.1
prevents subsequent ankyrin binding, probably playing
an important role in the regulation of ankyrin binding to
CD44 [95].
Apart from the binding of membrane proteins, pro-
tein 4.1 was shown to interact directly with membrane
phospholipids, mainly phosphatidylserine (PS), through
the N-terminal 30 kDa domain of protein 4.1, as charac-
terized by Sato and Onishi [112]. The PS binding site
was found in the sequences encoded by exons 10 and/or
11 [2]. The positively charged YKRS motif (residues
442-445) proved important for the initiation of interac-
tion between protein 4.1 and the negatively charged sur-
face of PS [2]. Futhermore, a tight hydrophobic interac-
tion of fatty acyl chains with the cluster of hydrophobic
residues near the YRKS motif was suggested [2]. Asso-
ciation with PS prevents the interaction of 4.1 with any
of the membrane proteins [2]. The localization of a PS
binding site in the FERM domain, which is present in
most of the protein 4.1 superfamily members, could be a
clue for the biological significance of the domain. 
The recently published data showed that 4.1R bound
to PIP2-containing liposomes through its FERM domain
and this binding induced a conformational change in this
domain [4]. Binding of PIP2 to 4.1R selectively modu-
lated the ability of 4.1R of interaction with its different
partners, e.g. PIP2 significantly enhanced binding of
4.1R to glycophorin C in situ in the membrane [4]. This
is in contrast to the FERM domain of focal adhesion
kinase (FAK), which does not bind PIP2 [19].
Protein 4.1R in nucleated cells
The existence of multiple isoforms of 4.1R in nucleated
cells indicates that it has a much more sophisticated role
there than in red blood cells. 4.1R epitopes were detect-
ed at different intracellular sites, and the association of
4.1R with various cellular proteins has been reported
[60, 82, 94], suggesting that 4.1R may be involved in
many processes in nucleated cells. Proteins interacting
with 4.1R and possessing predominant extranuclear
localization and function, such as actin, were detected
also in the nucleus. There is a strong possibility that 4.1R
can take part in the organization of the nuclear architec-
ture. 
The identification of signals involved in intracellular
localization of 4.1R proteins revealed that of the seven
isolated 4.1R cDNAs, four localized predominantly to
the nucleus and the other three to the cytoplasm [75]. A
comparative analysis of the exon composition of the nat-
urally occurring 4.1R cDNAs showed that all 4.1R mol-
ecules contained a conserved region encoded by consti-
tutive exons, named the "core region", which determines
the nuclear localization, which is able to confer nuclear
targeting to a cytosolic reporter. The nuclear localization
signal was identified in the alternative exon 16. Exon 5-
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encoded sequences blocked nuclear entry of the core
region, resulting in 4.1R isoforms being predominantly
distributed to the cytoplasm. Exon 5 was also able to
confer cytoplasmic localization to a nuclear reporter. In
the case of simultaneous expression of exons 5 and 16,
the nuclear targeting effect of exon 16 was dominant
over the inhibitory effect observed due to the expression
of exon 5 [75]. Further studies identified the amino acid
sequence responsible for the cytoplasmic localization of
4.1R isoforms expressing exon 5. Exon 5 encodes a
hydrophobic, leucine-rich sequence
(L26LKRVCEHLNLL) that is very similar to the
sequences of nuclear export signals (NESs) [76]. This
sequence adopts an α-helical conformation that is simi-
lar to the topology employed for the NESs of other pro-
teins with two conserved leucine residues (L34 and L36),
which in NESs are critical for 4.1R cytoplasmic local-
ization. The leucine-rich sequence is required for 4.1R
binding to the export receptor CRM1 in a RanGTP-
dependent fashion [76]. The leucine-rich sequence in
4.1R probably controls the distribution and function of a
specific set of 4.1R isoforms. Although the physiological
role of 4.1R isoforms containing the leucine-rich
sequence remains still unknown, they are candidates for
being part of the information transmission system
between the cytoplasm/plasma membrane and the nucle-
us. In vivo and in vitro biochemical analyses indicate an
association between 4.1R and microtubules. Analysis of
the distribution of 4.1R in human T cells shows that both
exogenous and endogenous 4.1R colocalize with the
microtubule network [100]. Transfection experiments of
T-cell 4.1R cDNAs in conjunction with confocal
microscopy showed the colocalization of exogenous
4.1R isoforms with the tubulin skeleton. A 22-amino
acid sequence in the constitutive core region, which con-
tains 7 repeats of leucine residues, was essential for tubu-
lin binding [100]. The 4.1R interaction with interphase
microtubules seems to play a role in the organization of
microtubule architecture and the mitotic spindle poles.
Protein 4.1R may also play a key role at the centro-
some, contributing to the maintenance of a radial micro-
tubule organization [101]. Specific 4.1R isoforms dis-
turbed the microtubule architecture but did not affect the
actin cytoskeleton. In microtubule depolymerizing-
repolymerizing assays, 4.1R-transfected cells showed a
similar ability to depolymerize and nucleate micro-
tubules to that of untransfected cells. In microtubule-
depolymerized transfected cells and during the initial
steps of microtubule regrowth, centrosomal 4.1R co-
localized with gamma-tubulin. This colocalization was
not observed when the microtubules became dissociated.
Further studies showed that 4.1R was present in isolated
centrosome preparations, and that it remained in the cen-
ter of microtubule asters [101]. Further studies might
prove that protein 4.1R plays an essential role in the reg-
ulation of many processes in non-erythroid cells.
The protein 4.1 superfamily
All the members of the protein 4.1 superfamily contain
a region known as the FERM (or ERM) domain at the
N-terminus of the molecule (Fig. 2). Its consensus
sequence is as follows: W - LIV- x(3) - KRQ- x - LIVM-
x(2) - QH- x(0,2) - LIVMF- x(6,8) - LIVMF- x(3,5) - F
- FY- x(2) - DENS [(PROSITE Database of protein fam-
ilies and domains (http://www.expasy.org/prosite/)
identifier: PS00660; FERM domain signature 1
(PATTERN)]. The widely distributed FERM family
contains more than 40 identified members. The family
is generally divided into five subfamilies on the basis
of protein sequence similarity: (1) protein 4.1 mole-
cules, (2) ERM proteins, (3) talin-related molecules,
(4) PTPH (protein tyrosine phosphatase) proteins, and
(5) NBL4 (novel band 4.1-like 4) proteins [128]. In the
talin subfamily, one member with two isoforms has
been identified so far. Proteins from subfamilies 4 and
5 lack actin-binding domains. Lately, new members of
this family, such as URP1 [137] or willin [47], have
been found.
The protein 4.1 family
The protein 4.1 family includes four well-defined
members: erythroid protein 4.1 (4.1R), the best-
known and characterized member, 4.1G (general),
4.1N (neuronal), and 4.1 B (brain) [95, 134, 142].
Besides three highly conserved domains, proteins
from this family contain several unique domains: U1,
U2 and U3 [36] (Fig. 3), their function remains
unknown. Actually the "true" 4.1 proteins are charac-
terized in vertebrates by their FERM, SAB and CTD
regions. Sequence aligment of the 4.1R, 4.1G, 4.1N
and 4.1B reveals that a high level of sequence identi-
ty extends beyond the end of FERM domain, and into
the 16 kDa region [97]. Indeed, the CTD is the
unique defined characteristic domain of all true 4.1
proteins since the Drosophila 4.1 homologue (D4.1),
localized to the septate junctions of epithelial cells
and encoded by the coracle gene, lacks the SAB
domain [32].
The presence of similar domains makes 4.1 homo-
logues candidates for participation in analogous
processes to 4.1R [58]. Unfortunately, although the
YKRS motif of the FERM domain is highly conserved
in all three proteins (4.1G, 4.1B and 4.1N), there is no
data on their interaction with PS. All the members of
the protein 4.1 family are highly expressed in human
nervous tissue. The results of real-time PCR experi-
ments indicate that mRNA for 4.1R is mainly present
in the bone marrow, cerebellum, lungs, testes and thy-
mus. 4.1G mRNA is widely expressed in the brain,
spinal cord and testes, while 4.1N mRNA is found in
the brain, spinal cord and adrenal gland, and 4.1B
mRNA in the testes, brain, spinal cord and kidneys
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[130]. 
Protein 4.1N (UniProtKB/Swiss-Prot: Q9H4G0),
also known as type I brain 4.1 (genes KIAA0338 or
EPB41L1), is a neuronal homologue of erythrocyte
membrane cytoskeletal protein 4.1 (4.1R). It contains
881 amino acid residues (molecular mass 98503 Da),
and respectively shares 70, 36, and 46% identity with
4.1R in the defined membrane-binding, spectrin-actin-
binding, and C-terminal domains. It should be men-
tioned that 4.1N SAB domains are actually quite diver-
gent from other such domains and does not bind spec-
trin/actin [40]. Protein 4.1N can stabilize the plasticity
of the neuronal membrane via interactions with the
spectrin-actin-based skeleton, integral membrane
channels and receptors, and membrane-associated
guanylate kinases [104]. Protein 4.1N is expressed in
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Fig. 2. The crystal structures of the FERM domains of: 4.1R (A, PDB accesion
number: 1GG3) [49], ezrin (B, PDB accesion number: 1NI2) [122], radixin (C,
PDB accesion number: 1GC7) [48], merlin (D, PDB accesion number: 1ISN)
[121] and talin (E, PDB accesion number: 1MIX) [35].  Reproduced from Protein
Data Bank (http://www.rcsb.org/pdb). 
almost all the central and peripheral neurons of the
mammalian body, and is detected in embryonic neu-
rons at the earliest stage of post-mitotic differentiation.
The regions of synaptic contact between neurons
potentially playing a role in synaptic architecture and
function are enriched in this homologue [136]. And not
only this one. Antibodies to each of 4.1R, 4.1G, 4.1N
and 4.1B recognized polypeptides in postsynaptic den-
sity preparations, it means that specific isoforms of all
four 4.1 proteins are components of postsynaptic den-
sities [115]. Each of these proteins coisolate with post-
synaptic complexes enriched in NMDA (N-methyl-D-
aspartate) receptors [21]. In the context of the earlier
discussion of 4.1 phosphorylation we should mention
that Collins et al. showed that postsynaptic 4.1 pro-
teins are phosphorylated in vivo [21].
Protein 4.1B (human, UniProtKB/Swiss-Prot:
Q9Y2J2) or type II brain 4.1 (genes KIAA0987,
EPB41L3) is also a neuronal, brain-enriched homo-
logue with a molecular mass of 145 kDa (1087 amino
acid residues, molecular weight: 120678 Da); it was
localized in neuronal populations in the mouse brain,
especially in the Purkinje cells of the cerebellum,
pyramidal cells in the hippocampal regions CA1-3,
thalamic nuclei, and the olfactory bulb [97, 104]. In
addition, it was found in the heart, lungs, kidneys,
intestine and testes. This homologue is subcellularly
localized at the plasma membrane in regions of cell-
cell contact [97]. Recent data concerning the structure
and distribution of three members of the protein 4.1
family, 4.1B, 4.1R and 4.1N, in the mouse kidney indi-
cates potential functions for 4.1 proteins in the kid-
neys, such as organization of signaling complexes,
response to osmotic stress, protein trafficking, and
control of cell proliferation [18, 104].
Protein 4.1G (human, UniProtKB/Swiss-Prot:
O43491) (EPB41L2), located on human chromosome
6q23, is a widely expressed homologue found in brain
tissue, especially in cultured hippocampal neurons. It
also occurs in the heart, placenta, skeletal mucles,
lungs, kidneys, pancreas and gonads [98, 102]. The
complete nucleotide sequence of 4.1G cDNA predicts
a 113-kDa protein that exhibits three regions of high
homology to protein 4.1R (1005 amino acid residues,
molecular weight: 112588 Da). In COS cells, protein
4.1G was found in the cytosol, perinuclear area and
centrosomes [98].
Recently, Ni et al. discovered a novel human form
named 4.1O (ovary), containing 553 amino acid
residues [90]. The 4.1O gene consists of 14 exons and
13 introns and was located on chromosome 9q21-9q22
using bioinformatic analysis [90]. Recent data indicate
however, that 4.1O is not a member of the true 4.1 fam-
ily and is actually a member of poorly characterized
family of FERM and transmembrane domain proteins
(two in vertebrate genomes, one in invertebrates) [6]. 
The ERM family
The ERM family includes ezrin, radixin, moesin and
merlin. The proteins of the ERM family are close homo-
logues with about 75% sequence identity [5, 127, 133].
Radixin (~80 kDa), ezrin (~82 kDa) and moesin (~75
kDa) are very closely related to the protein 4.1 super-
family. They possess N-terminal FERM (ERM) domain
(Fig. 2B-D) consisting of about 300 residues, also called
N-ERMAD (N-terminal ERM association domain), and
an about 100-residue long C-terminal domain C-
ERMAD (C-terminal ERM association domain), where
the last 34 residues form an F-actin-binding site (ABD)
[134]. The domains are separated by an α-helical, coiled
coil region (CRR). Additionaly, two actin-binding sites
have been identified in the middle and N-terminal
domains (Fig. 3) [82, 111]. The ERM domains share
about 30% sequence homology with the 30 kDa domain
of 4.1R. Merlin is structurally similar to the ERM pro-
teins, but instead of an actin-binding domain (ABD), it
contains a C-terminal domain (CTD), just like the pro-
teins from the 4.1 family (Fig. 3). Homologues of the
ERM family of proteins have also been found in genet-
ically-tractable model organisms, like Drosophila
melanogaster and Caenorhabditis elegans. However,
only one gene in flies [137] and two nearly identical
genes in nematodes were found [135]. Activated ezrin,
radixin and moesin are probably involved in the linking
of actin filaments to CD43, CD44, ICAM1-3 cell adhe-
sion molecules, various membrane channels and recep-
tors, such as the Na+/H+ exchanger-3 (NHE3), cystic
fibrosis transmembrane conductance regulator (CFTR),
and the β2-adrenergic receptor [14, 133]. With the help
of the PCR method, some other members of the 4.1
superfamily were identified. Seven cDNA clones
encoded novel NBL 1-7 proteins [128]. Two of them,
NBL6 and NBL7, demonstrated high similarity to the
corresponding sequences of the ERM family.
Ezrin. Ezrin, also called cytovillin or p81, was first iso-
lated and identified as a protein localized under the plas-
ma membrane of chicken intestinal microvilli [14]. The
name of ezrin came from Ezra Cornell University, where
it was first purified. The ezrin gene is located on human
chromosome 6 (13 exons). Ezrin obtained from the
human placenta was subsequently recognized as a good
substrate for some tyrosine kinases in vivo [14]. Human
ezrin (UniProtKB/Swiss-Prot: P15311) contains 585
amino acid residues, and its molecular weight is 69268
Da. The N-terminal 296 residues of ezrin fold into a N-
ERMAD domain that associates with the C-terminal
107-residue C-ERMAD domain containing an F-actin
binding site [36]. The ERM domain contains binding
sites for several proteins - CD44, EBP50 (PDZ-contain-
ing phoshoprotein) and Rho-GDI (Rho pathway regula-
tor) - and also for the signaling phospholipid phos-
phatidyl-inositol 4,5-bisphosphate (PIP2) [15]. Between
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the main domains, there is a 172-residue long α-helical
domain containing the binding site for the RII-regulato-
ry subunit of PKA [28], and a very short, 7-residue long
polyproline segment. It is suggested to play a role in the
Rho signaling pathways, e.g. in the activation of Rho
through the sequestration of Rho-GDI [125]. Ezrin is
mostly associated with the membrane and various mem-
brane and cytoskeletal components, such as CD44,
EBP50 and, of course, F-actin [15]. It was also shown to
associate with PIP2-containing liposomes via its N-ter-
minal domain. Using internal deletions and C-terminal
truncations, the PIP2 binding site was located to amino
acid residues 12-115 and 233-310, in regions containing
a KK(X)(n)K/RK motif, which is conserved in the ERM
family [7]. Ezrin is involved in the control of cell surface
topography through the regulation of the cortical
cytoskeleton structure. It also takes part in the regulation
of acid secretion in the parietal cells of gastric glands
[50, 51].
Radixin. Radixin was identified as a barbed-end-cap-
ping, actin-modulating protein. It was found in cell-to-
cell adherens junctions from rat liver and in the cleav-
age furrow in mitotic cells [132]. This protein is very
similar to ezrin - 75% overall identity and 85% identity
for the N-terminal domain [34]. The gene for radixin is
located on human chromosome 11 (11 exons) [138].
Human radixin (UniProtKB/Swiss-Prot: P35241) con-
sists of 583 amino acid residues (molecular weight:
68564 Da). Its α-helical domain is an extremely long
(24 nm in length from N- to C-terminus), linear, stable
rod (amino acid residues 311-469). The α-helical radix-
in domain residues are available for electrostatic inter-
actions and surface salt bridges that contribute synergis-
tically to its thermal stability [56, 57]. This domain is
required for regulating the formation of the functional
cortical layer, including attachment of actin filaments to
the membrane and possibly organization of the mem-
brane transporters and channels [57].
The regulation of radixin function occurs via confor-
mational changes in the protein structure. The open and
closed forms represent the active and inactive molecules
[64]. Intramolecular associations between ERM and
CTD domains inhibit the membrane- and actin-binding
activities of radixin. The protein itself is thought to
acquire an inactive globular closed form, as shown
using low-angle shadowing electron microscopy [64].
Phosphorylation of radixin and/or PIP2 binding leads to
an elongated, open form with two associated globular
structures on its two ends; these can form actin-mem-
brane linkages. Both closed and open conformations of
radixin can coexist in a population [57]. Similarly to
ezrin and moesin, activated radixin has been shown to
attach actin microfilaments to CD 43, CD 44 and ICAM
1-3 cell adhesion molecules and to various membrane
channels and receptors, such as cystic fibrosis trans-
membrane regulator (CFTR), Na+/H+ exchanger 3
(NHE3) or β2-adrenergic receptor [14, 133].
Moesin. Moesin (UniProtKB/Swiss-Prot: P26038), a
membrane-organizing extension spike protein (576
amino acid residues, Mr = 67689 Da for human moesin),
was first discovered as an extracellular heparin-binding
protein. It was isolated from bovine uterus smooth mus-
cle cells. Later, moesin was shown to occur intracellular-
ly [71]. The genes for moesin reside on human chromo-
some X (12 exons). Moesin is composed of the same
domains as the other members of the ERM family (Fig.
3). Following the N-terminal FERM domain is a 200-
residue long region predicted to be largely α-helical, and
a C-terminal tail domain consisting of 100 residues [71].
Its FERM domain consists of three subdomains similar
to A, B, C subdomains of 4.1 FERM domain. The first,
named F1 (residues 5-82), has a structure similar to ubiq-
uitin, and contains five β-sheet strands with an α-helix
running across it. The next subdomain, F2 (residues 96-
195), shows similarity to acylCoA-binding protein, and
is almost α-helical with a short linker region of 30
residues between the second and third of four helices.
The final, F3 (residues 204-296), is composed of two
antiparallel β-sheets followed by an α-helical fragment
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Fig. 3. A comparison of the structural domains present in the main
members of the protein 4.1 superfamily, references in brackets.
Domains: A, B, C - FERM subdomains (lobes), ABD - actin bind-
ing domain, BB - blue box, CTD - carboxyl terminal domain, DHR
- Drosophila hormone receptor, FERM - 4.1-ezrin-radixin-moesin
domain, F1, F2, F3 - FERM subdomains, PDZ - postsynaptic den-
sity-95 /discs large/zonula occludens-1 domain, PH - pleckstrin
homology domain, PTP - protein tyrosine phosphatase domain,
SABD -spectrin-actin-binding domain, TKPD - tyrosine kinase
phosphorylation domain, U1-3 - unique regions, VinBS - vinculin
binding site. 
with a sequence similarity to the pleckstrin homology
(PH), phosphotyrosine-binding (PTB), and
enabled/VASP homology 1 (EVH1) domains [31].
Moesin and radixin are 90% identical in the region of
residues 1-297, and are considered isoforms with a sim-
ilar function. Protein 4.1 is much more distantly related,
showing only 16.5% sequence identity in the structural
alignment with moesin [31]. Moesin is the quantitative-
ly dominant ERM protein in human blood lymphocytes,
monocytes and neutrophils [117], and the only one in
human platelets [88]. In Drosophila, only one protein
from the ERM family was identified - Dmoesin [84].
Dmoesin plays a role in the localization of determinants
in the oocyte posterior cortex. 
Merlin. Merlin (595 amino acid residues, Mr = 69690 Da
for human merlin), i.e. moesin-ezrin-radixin-like protein
(UniProtKB/Swiss-Prot: P35240), is also called NF2 or
schwannomin (for its role in preventing schwannoma for-
mation) [109, 131]. This protein is encoded by 17 exons
with alternative splicing of the exon producing 2 major
isoforms [46]. Isoform 1, encoded by exons 1-15 and 17,
is a 595-amino acid residue protein that is composed of
three domains (Fig. 3): N-terminal FERM domain that
precedes a long α-helical, proline-rich region and is fol-
lowed by a unique C-teminal domain [46, 66]. The
FERM domain of merlin contains 3 subdomains, labeled
A (residues 1-98), B (residues 112-212), and C (residues
212-311), and has a unique Blue Box (BB, residues 177-
183) [73]. The FERM domain of merlin is responsible for
membrane binding in a PIP2-dependent manner [48]. C-
teminal domain of merlin is different from CTDs of true
4.1 proteins and is actually recognised by the hidden
Markov model (HMM) for ERM CTDs [6]. Isoform 2 is
a 590-amino acid residue protein formed as a result of an
insertion in exon 16 that provides a new stop codon. This
isoform differs from isoform 1 only at the C-terminus.
Merlin lacks the conserved actin-binding site at its C-ter-
minus, characteristic for the other members of the FERM
family. However, it has alternative actin-binding sites
inside the ERM domain [140]; these interact with
cytoskeletal actin. The two isoforms differ in their regu-
lation of this interaction. Like the other ERMs, isoform 1
can exist in the closed state where the N- and C-terminal
regions undergo an intramolecular interaction, masking
the conserved actin-binding site, which must be disrupted
(by phosphorylation or interaction with phosphoinosi-
tides) to produce the open state, in which this interaction
is possible [54, 141]. Isoform 2 always occurs in the open
state and is presumably available for interaction with
actin and other proteins. The ability of merlin to change
conformational states with a different capacity for inter-
molecular interactions could be important in the signaling
by the Rho pathway, which regulates the reorganization
of the actin cytoskeleton [125]. Merlin is involved in reg-
ulating cell proliferation and motility by integrating the
growth-promoting and arrest signals initiated by CD44
and hepatocyte growth factor receptor activation, and
probably plays a role in integrating multiple cell-signal-
ing pathways [105]. Merlin can also indirectly associate
with the skeleton through its interaction with  βII spectrin
[114]. As in the other ERM family proteins, the FERM
domain of merlin is responsible for membrane binding in
a PIP2-dependent manner [48].
Talin. The talin family in mammals consists of two gene
products: TLN1, coding for a 2541-amino acid residue
long protein (UniProtKB/Swiss-Prot: Q9Y490), and
TLN2, coding for a protein one amino acid residue short-
er (UniProtKB/Swiss-Prot: Q9Y4G6). Both isoforms are
multifunctional proteins with a molecular mass of about
270 kDa [106], localized in a variety of mammalian cells;
they are found in cell-extracellular matrix adherens-type
junctions, in focal adhesions of adherent cells, in skeletal
and cardiac muscle cells [24] and in the membrane ruffles
of migrating cells [16], and are concentrated in the under-
coat of cell-to-substrate adherens junctions [11, 16, 17].
Talin plays an important role in initiating actin filament
growth in motile cell protrusions [25]. This protein is
responsible for linking the cytoplasmic domains of inte-
grins to the actin-based cytoskeleton, and is involved in
vinculin, integrin and actin interactions [11]. In platelets,
talin redistributes from the cytoplasm to the membrane
upon activation, which leads to secretory events and
platelet coagulation via integrins [10]. Analytical ultra-
centrifugation of native talin, chemical cross-linking with
glutaraldehyde and SDS-PAGE analysis showed that in
its native biological state, talin forms an antiparallel rod-
like homodimer with an average length of 51 nm [41].
The N-terminal region of talin contains a FERM domain
(47 kDa, amino acid residues 86-410) (Fig. 2E). It shares
20% sequence identity with protein 4.1 and 23% with
ezrin [104]. The FERM domain is made up of 3 subdo-
mains (F1, F2, F3) connected by short linkers. Recently,
the crystal structure was determined of a part of the chick-
en talin FERM domain containing the F2 (residues 209-
304) and F3 (residues 311-400) subdomains [35] (Fig. 3).
The talin rod comprises approximately 60 alanine-rich
repeats [87]. It was found to contain a significant propor-
tion of the α-helical structure [91]. The rod is very long
(219 kDa) and is ended by a highly conserved C-terminal,
the best characterized actin-binding site (residues 2345-
2541) ABS3. This is one of the three actin-binding
domains located in talin [53]. One of the remaining actin-
binding sites is exposed in the talin rod (residues 951-
1327, ABS2) and the other within the talin FERM
domain (residues 102-497, ABS1) [72]. Both the F2 and
F3 FERM subdomains contribute to F-actin binding.
Actin binding is correlated with the binding and activa-
tion of integrin. Subdomain F3 of the FERM domain con-
tains overlapping binding sites for integrin cytoplasmic
domains and for the type 1 gamma isoform of PIP-kinase
241Protein 4.1/FERM superfamily
(phosphatidylinositol 4-phosphate 5-kinase) [8]. The
interaction of PIP-kinase with talin in the presynaptic
compartments determines the mechanism for PIP2 syn-
thesis, actin dynamics, endocytosis, and functional con-
nections between actin and clathrin-mediated endocytosis
[85]. The large C-terminal domain contains the second
integrin-binding site [72]. The 219 kDa rod fragment of
talin contains three sites known to have vinculin-binding
activity: residues 498-656, 852-950 and 1929-2029 [9,
53] (Fig. 3). 
Talin is structurally and functionally regulated by
interactions with the membrane key regulatory lipid -
phosphatidylinositol 4,5-biphosphate (PIP2) [39, 80].
The binding of its N-terminal domain, enriched in
basic amino acids [106], with the negatively charged
head groups of PIP2 is thought to play a significant
role in the regulation of adhesion dynamics [89].
Two small segments of the 47 kDa head part of the
talin homodimer, named S19 and H17, respectively con-
taining 21-39 and 385-406 amino acid residues, were
found to mediate the interaction with the lipid membrane
[118]. These peptides, synthesized separately, can pene-
trate the POPC/POPG and POPC monolayers. Amino
acid residues 385-406 (H17) may represent a potential
membrane-anchoring domain. The helical wheel projec-
tion shows its amphipatic character. Amino acid residues
21-39 (S19) could provide an additional (hydrophobic
and electrostatic) contribution of talin anchorage in the
lipid membrane [118]. The strong amphipatic nature of
talin peptide and the hydrophobicity gradient along its
sequence suggest a partial penetration of the lipid bilay-
er that can destabilize it and lead to inverted micelle for-
mation, which triggers membrane fusion as observed by
cryo-electron microscopy [62].
The PTPH family
Protein tyrosine phosphatases belong to larger family of
PTPs containing FERM domain, but till now the PTPH
protein family consisted of only two well-defined mem-
bers: PTPH1 and PTPMEG. These proteins are con-
structed predominantly from the N-terminal FERM
domain and a C-terminal (260 residues) protein tyrosine
phosphatase (PTP) catalytic domain [45]. The other pro-
teins, such as PTP36/PTPD2/Pez or PTPD1/PTP-RL10,
or the largest known cytoplasmic PTP, the 250 kDa
PTPL1, are predominantly localized in the apical region
of the plasma membrane and in the dorsal microvilli of
HeLa cells [13]. As in the other members of FERM fam-
ily, there are two potential PIP2-binding motifs within
the FERM domain of PTPL1; these are probably respon-
sible for the intracellular targeting of PTPL1 [13].
PTPH1. PTPH1 (protein tyrosine phosphatase Hela1,
UniProtKB/Swiss-Prot: P26045) was isolated as a puta-
tive intracellular PTP from a HeLa cell cDNA library. Its
open reading frame encodes a protein of 913 amino acid
residues with Mr = 104030 Da [143]. Along with N- and
C-terminal domains, it contains a central segment bear-
ing putative phosphorylation sites for protein-
serine/threonine kinases (Fig. 3). PTPH1 may act as a
linker between the plasma membrane and the cytoskele-
ton, e.g. in focal adhesions - specialized regions of the
plasma membrane through which cells adhere to the
external substrate, anchoring actin stress fibers [17].
PTPH1 was reported to regulate cell cycle progression
by dephoshporylating valosin-containing protein [144]
and is capable of interacting with and dephosphorylating
the T-cell receptor ζ subunit [123]. Through binding of
the PDZ domain of PTPH1 to the C-terminal part of
TACE, PTPH1 can also interact with tumor necrosis fac-
tor alpha-convertase (TACE), a metalloprotease
involved in the ectodomain shedding of several proteins
and critical for proper murine development. This inter-
action leads to the inhibition of TACE. This is the first
evidence of the regulation of TACE by a cytoplasmic
protein [145].
PTPMEG. PTPMEG (protein tyrosine phosphatase,
megakaryocyte) was isolated from the human MEG-01
cell line. It has a predicted Mr = 105780 Da with 926
amino acid residues (gi:4506295 for human protein tyro-
sine phosphatase, non-receptor type 4, UniProtKB/
TrEMBL:Q9WU22 for mouse gene Ptpn4 product). It
has two functional domains: a protein 4.1 homology
domain and a tyrosine-phosphatase domain, separated
by 292 amino acid residues unrelated to any previously
sequenced protein [45]. Within the intermediate domain,
multiple sites of serine and threonine phosphorylation
were found (between amino acids 386 and 503). This
region also contains two PEST sequences (residues 436-
461 and 490-503) and two proline-rich motifs (residues
389-397 and 462-468) that may confer the ability to bind
to Src homology 3 domains. In the C-terminal part of this
domain, a DHF motif was found (residues 518-599)
(Fig. 3) [43]. The function of this fragment remains
unknown; it could presumably play a role in the interac-
tion with some other molecules or control the activity of
the phosphatase domain [43]. In the COS-7 cell lines,
PTPMEG can inhibit cell proliferation, reduce saturation
density, and block the ability of these cells to grow with-
out adhering to a solid matrix [44]. PTPMEG associates
directly with the mouse GluRdelta2 (glutamate receptor
delta2 subunit, selectively expressed in cerebellar Purk-
inje cells) and plays a role in the downstream signaling
of the GluRs and/or in the regulation of their activities
through tyrosine dephosphorylation [55]. The homology
between the N-terminal domain of PTPMEG and protein
4.1 suggests that this protein can attach to a glycophorin-
like transmembrane molecule and could have a
cytoskeletal association with an additional PTPase activ-
ity that may influence the cytoskeletal rearrangement,
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organization and regulation of cytoskeletal events [43,
44]. This family may become bigger: there are three
cDNA clones, NBL1, NBL2 and NBL3, with high
sequence homology to PTPH1/PTPMEG [128]. 
The NBL4 family
The last two clones (NBL4 and NBL5) mentioned by
Takeuchi [128] form the NBL4 protein family. These
proteins are not very closely related to any of the known
members of the protein 4.1 superfamily. There are sever-
al isoforms of NBL4: human (hNBL4, UniProtKB/
Swiss-Prot: Q9HCS5) with 598 residues and Mr = 69375
Da, murine (mNBL4, UniProtKB/ Swiss-Prot: P52963)
[120] with 554 residues and Mr = 64082 Da, and
zebrafish NBL4 (UniProtKB/Swiss-Prot: O57457) [67]
with 619 residues and Mr = 70709 Da. There is no clear
data on the appearance or role of NBL5. A comparison
of the predicted amino acid sequences of these proteins
indicated a high degree of similarity of the overall struc-
tures (87% and 71%, respectively) [63]. The deduced
overall structures of hNBL4 and mNBL4 indicate the
presence of two FERM subdomains (amino acid
residues 70-102 and 181-210) separated by a small tyro-
sine kinase phosphorylation domain [63] (Fig. 3). The
examination of various types of human cancer showed
that NBL4 is an important component of the β-
catenin/Tcf signaling pathway, and therefore is probably
involved in establishing the cell polarity or proliferation
[63]. NBL4 may be also involved in adhesion, in cell
motility and/or in cell-to-cell communication [63]. 
New members of protein 4.1 superfamily
Despite the variety and diversity of the protein 4.1 iso-
forms discovered in the eighties and nineties, new mem-
bers of protein 4.1 superfamily are still being recognized.
One of the examples could be the urp1 gene, found dur-
ing the identification of biomarkers of human lung and
colon carcinomas [138]. URP1 reveals a strong sequence
homology to the previously characterized C. elegans
gene, UNC-112 [105]. URP1 is also closely related to
other novel genes, URP2 and the previously discovered
human mitogen-inducible (MIG-2) gene. The genomic
structure for all three genes is nearly identical, all being
encoded by 15 exons, although the URP1 gene localized
to chromosome 20p13, URP2 to 11q12, and MIG-2 to
14q22. This conserved exon structure suggests that all
three members probably arose by gene duplication from
one ancestral gene. The predicted UPR1 polypeptide is
677 residues long an expected molecular mass of 77408
Da (GenBank accession number: AF443278). URP1,
URP2, MIG-2, and two genes from Drosophila
(CG7729 and CG14991) share a unique domain struc-
ture consisting of two FERM domains that surround a
PH domain and appear to form a novel membrane-asso-
ciated FERM and PH domain-containing protein family
(Fig. 3). The presence of multiple FERM domains char-
acteristic to many plasma membrane cytoskeleton link-
ers and a PH domain typical of membrane-anchored pro-
teins involved in signal transduction suggests an impor-
tant role for URP1 in tumorigenesis [138]. 
Another member is a new FERM domain-containing
protein called willin [47], the result of the yeast two-
hybrid screening of the transmembrane L1 family mem-
ber neurofascin that identified a novel FERM-containing
cDNA. This cDNA clone from human uterine leiomyo-
sarcoma tissue was sequenced and found to contain 614
amino acid residues (about 71 kDa), with the FERM
domain within its N-terminus (residues 14-322) and a
localization and length similar to the ERM proteins [47]
(Fig. 3). Immunohistochemical studies indicated that
willin can have different intracellular distribution. In the
oral mucosa squamous cell carcinoma it is localized pre-
dominantly in the cytoplasm, but was also found along
the plasma membrane. In the plasma membrane, willin
can co-localize with actin, which is commonly observed
for the protein 4.1 superfamily members. The chimeric
GST-willin showed the same phospholipid-binding pro-
file as purified GST-moesin [47]. 
Apart from these, there are many other proteins con-
taining the FERM domain that could in the future be
classified as new members of the protein 4.1 or FERM
family. One of these could be a focal adhesion kinase
(FAK), which is a non-receptor tyrosine kinase that
localizes to focal adhesions in adherent cells [19]. The
N-terminal region of FAK contains a fragment that
shares the sequence homology with band 4.1 and ERM
proteins, a FERM domain. Three subdomains (F1, F2,
and F3) form a tertiary fold, similar to those of known
FERM structures despite the low sequence conserva-
tion (only 12-15% sequence identity with ERM family
members). The difference concerns the sequence and
relative orientation of the F3 subdomain that alters the
nature of the interdomain interface. A putative protein
interaction site on the F3 lobe is masked by the proxi-
mal region of the linker. The phosphoinositide-binding
site found in ERM family proteins is absent in the
FERM domain of FAK. The adjacent Src SH3 and SH2
binding sites in the linker of FAK can associate with the
surfaces of the F3 and F1 lobes. These structural fea-
tures suggest the possibility that interactions of the
FAK FERM domain can be regulated by binding of Src
kinases to the linker segment [19]. Deletion analyses
suggest that the FERM domain of FAK can inhibit
enzymatic activity and repress FAK signaling [29]. The
purified FERM domain of FAK can interact with full-
length FAK in vitro, and mutation of this sequence dis-
rupts the interaction.
In an inactive state of FAK, the FERM domain (espe-
cially the F2 subdomain) is believed to interact with the
catalytic domain of FAK to repress its activity. This
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interaction may be disrupted upon activation, and the
enzyme can expose its kinase activity [29].
Protein 4.1 evolution
The variety of protein 4.1 superfamily members suggests
the involvement of these proteins in many cellular
events. The comparative analyses of the amino acid
sequences of the N-terminal domains of these proteins
allowed the estimation of the genetic distances and pos-
sible evolutionary relationships between the FERM fam-
ily members [128]. Based upon this data, the presumable
phylogenetic tree was constructed using the unweighed
pair-group method [33]. Using this interpretation, talin
and the primordial form of the other members of the pro-
tein 4.1 family were generated first. The subsequent dif-
ferentiation of the primordial form of the FERM family
members led to band 4.1 "prefamily" and ERM "prefam-
ily" proteins, and then the band 4.1 "prefamily" differen-
tiated into the band 4.1, NBL4/5 and PTPH1 families.
The ERM "prefamily" differentiated into the ERM fami-
ly, merlin and the NBL6/7 family, respectively [128]. 
Recently, more precise studies concerning the evolu-
tion of merlin in comparison to the other ERM family
proteins were based on phylogenetic analysis of 50 pro-
teins of the ERM family which were identified from 30
different taxa [42]. Using the neighbor-joining method
[68] combined with the molecular evolutionary genetics
analysis program MEGA2 [69], the phylogenetic tree of
the ERM family of proteins was constructed; the entire
ERM family could be subdivided into the ERM branch
and the merlin branch. While both branches have a
strongly supported monophyletic origin, the merlin
branch can be separated from the ERM branch and
divided into 3 groups according to the order of deriva-
tion: worms, insects and Chordata, with the earliest sep-
arated genus, Ciona, in the last taxonomic unit [42]. The
lack of a merlin-like sequence in many species of Platy-
helmithes and the absence of merlin-like sequences in
the complete genomes of protozoa, fungi and plants sug-
gests that the derivation of merlin occurred in the early
metazoa after their separation from flatworms. The
ERM-like proteins found in parasites can be grouped
together and form a branch separate from the rest of the
ERM proteins. In vertebrates, the ERM-like proteins evi-
dently expand, which occurred after separation from
Urochordata (Ciona intestinalis), and led to the appear-
ance of three related groups of proteins: ezrin (the most
ancient), radixin and moesin, and the increasing number
of ERM members paralleled the evolutionary complexi-
ty of the organism. Amino acid sequence alignment
reveals the absence of an actin-binding site in the C-ter-
minal region of all merlin proteins from various species
but the presence of a conserved internal binding site in
the N-terminal domain of the merlin and ERM proteins.
A more conserved pattern of seven amino acid residues
(170YQMTPEM177) was found in the N-terminal domain
of Drosophila merlin, called the "Blue Box"; these seven
are identical between human and Drosophila merlins
[70], although some amino acid substitutions in this
region exist in the merlin sequences of worms, fish, and
Ciona [42].
Secondary structure prediction reveals the presence
of a conserved α-helical domain in the central to C-ter-
minal region of the merlin proteins of various species.
The conserved residues and structures identified corre-
spond to the important sites highlighted by the available
crystal structures of the merlin and ERM proteins. Anal-
ysis of the merlin gene structures from various organ-
isms shows the increase in gene length during evolution
due to the expansion of the introns. However, a reduction
in intron number and length appears to occur in the mer-
lin gene of the insect group [42]. The overall similarity
among the primary and secondary structures of all the
merlin proteins and the conservation of several function-
ally important residues suggest a universal role for mer-
lin in a wide range of metazoa. 
Concluding remarks
Although a lot has been done to understand the structure
and role of protein 4.1 and the other FERM family mem-
bers, many details still remain unknown. To better under-
stand the protein 4.1 superfamily and its large diversity,
it is necessary to explain in which cellular events the pro-
teins from particular protein 4.1 subfamilies are
involved, and to examine how these proteins evolved
and how their functions diversified. In particular the
FERM domain seems to play specific roles in regulation
of activity of FERM proteins and determination of their
function. Recent data indicate a novel sequence domain,
the FERM-adjacent (FA) region detected in a subset of
many proteins containing FERM domain [6]. The pres-
ence of conservative motifs that are potential substrates
for kinases in this region suggests a possible regulatory
adaptation in this subset including substantial amount of
proteins: true 4.1 proteins, some tyrosine phosphatases,
rho-GEF proteins, type II transmembrane proteins and
many uncharacterised FERM proteins [6].
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